Mutations in the human p53 gene are the most frequent genetic event occurring during carcinogenesis in a wide variety of tumours [43]; in cell lines, loss of p53 activity is usually associated with several specific markers, such as defects in cell-cycle arrest or apoptosis after DNA damage [44]. This evidence concerns the gene TP53 and neoplasm.